Research Commitment Sample Clauses
A Research Commitment clause defines the obligations of a party, typically in a collaborative or sponsored research agreement, to conduct specific research activities or devote certain resources to a research project. This clause may outline the scope of the research, timelines, milestones, and the level of effort or personnel required. By clearly specifying these expectations, the clause ensures that all parties understand their responsibilities and helps prevent disputes over the adequacy or progress of the research work.
POPULAR SAMPLE Copied 2 times
Research Commitment. In consideration for the funding provided by Nanogen, Prolinx shall commit to the Sponsored Research Program a dedicated team consisting of such number of appropriately qualified scientists and support personnel per year for the duration of the Sponsored Research Program as is called for under the Research Plan, as modified annually or from time to time pursuant to Section 6.5 above. Upon the prior approval of Nanogen, which approval shall not be unreasonably withheld, Prolinx may change the composition of the dedicated team from time to time in its reasonable discretion to achieve the needs of the Sponsored Research Program. Prolinx shall use its best efforts to execute the Research Plan and to achieve the overall goals of the Sponsored Research Program. In using its best efforts, it is understood that Prolinx is not obligated to spend more than the Annual Research Fee as specified in Section 2.2 hereof, plus those expenditures specified in Sections 4.2 and 5.2 hereof. It is further understood that Prolinx does not guarantee the results of this scientific endeavor.
Research Commitment. During the Development Term, Roche shall diligently conduct the Development Program in accordance with the Development Plan, as revised from time to time by Roche. Without limiting the generality of the foregoing, each party shall devote to the Development Program such personnel as is reasonably necessary to conduct the activities for which such party is responsible as set forth in the Development Plan. Roche may request that Emisphere perform certain Development Plan activities; and if Emisphere agrees to perform such activities, it shall conduct such activities diligently. In addition, Emisphere shall promptly provide written reports of the status of such activities and the results from its performance of, such activities, in accordance with a schedule agreed upon by the parties. Roche shall compensate Emisphere for Development Plan activities (excluding activities relating to participation in, or preparation for, TLC meetings or relating to regulatory activities) performed by Emisphere personnel at a rate of *** per FTE-hour. On a *** basis, within forty-five (45) days of the end of the ***, Emisphere shall provide a written invoice to Roche specifying the
Research Commitment. During the Research Program Term, the Parties shall diligently conduct the Research Program in accordance with the Research Plan as revised from time to time by the JRSC. The Research Plan shall provide, inter alia, for tasks to be performed by Versicor with ten (10) FTEs during each year of the Research Program Term. Each Party shall conduct its activities under the Research Program in good scientific manner, and in compliance in all material respects with all requirements of applicable laws and regulations and with all applicable good laboratory practices and good manufacturing practices to attempt to achieve its objectives efficiently and expeditiously.
Research Commitment. During the Formulation-Development Term, Emisphere shall use commercially reasonable efforts to conduct its responsibilities under the Formulation-Development Program in accordance with the Formulation-Development Plan and Formulation-Development Budget, as revised from time to time by the TLC. Without limiting the generality of the foregoing, Emisphere shall devote to the Formulation-Development Program such personnel as is reasonably necessary to conduct all of Emisphere’s responsibilities required under the Formulation-Development Plan, it being understood that Genta is and will be responsible (a) under the Formulation-Development Plan only for the supply of cGMP quantities of Gallium Salt API (in the form of gallium nitrate or such Gallium Salt(s) as may be mutually agreed by the parties) to Emisphere in connection with formulation development, and (b) for the conduct of the Clinical Program (as set forth in greater detail in Article 4). Emisphere acknowledges that while the Formulation-Development Plan describes the principal activities that Emisphere is to perform under the Formulation-Development Program, Emisphere’s responsibilities under the Formulation-Development Program (and the reimbursement provided under Section 6.1) include all such activities that would normally be performed to perform such principal activities, including the analysis and compilation of results from such activities in a form appropriate for submission in an IND filing. Subject to the foregoing Genta acknowledges that Emisphere’s responsibilities under the Formulation-Development Program may not constitute all activities that are necessary to develop a Product for the * Field to the point of supporting the filing of an IND. In addition, Emisphere shall promptly provide written reports of the status of its activities under the Formulation-Development Plan and the results from its performance of such activities, in accordance with a schedule agreed upon by the parties, which shall be in any event at least monthly. Each party shall be solely responsible for the costs and expenses incurred in connection with its performance of Development Plan activities, subject to Section 6.1. Genta shall be responsible for the conduct of toxicology studies of Products that it deems appropriate, to the extent such studies are not otherwise covered by the Formulation-Development Plan. To the extent Genta conducts any toxicology studies of Products, Emisphere shall have no right to utilize the ...
Research Commitment. Applicant Institution agrees that Applicant Investigator’s time, facilities, and position will remain at an appropriate level to facilitate the Project.
Research Commitment. Subject to P&G’s compliance with its funding obligations under Section 6.2 hereof, Curis initially will devote to the Research Program at least [**] FTE Scientists and may devote such additional number of FTE Scientists as may be agreed by the RSC. During the initial 12-month period the Agreement may not be terminated, except in the case of failure of all, or all but one, of the Licensed Compounds to demonstrate [**] specified in the Research Plan, as determined reasonably and in good faith by the RSC in accordance with objective criteria established by the RSC. In the event of such failure, P&G may terminate the Agreement and related research obligations, with 45 days prior written notice. After the initial 12-month period, at three (3) month intervals during the Research Term, the RSC or the CDSC, as applicable, shall review the staffing needs to accomplish the objectives of the Research Program during the following three (3) months and may approve an increase or decrease to the number of FTE Scientists to be devoted to the Research Program by Curis (the “Curis Staffing Level”). P&G shall be obligated to fund that number of FTE Scientists of Curis required by the then-current Curis Staffing Level in accordance with Section 6.2 hereof; provided, however, that in no event shall P&G provide funding for fewer than [**] FTE Scientists during any Contract Year of the Research Term.
Research Commitment. During the Research Term, the parties shall diligently conduct their activities in accordance with the Research Plan, [*]. Without limiting the generality of the foregoing, it is contemplated that [*] with respect to Shared Programs prior to commencement of [*] for an Active Compound shall be [*] shall be conducted by [*], subject to [*] [*] [*] pursuant to Section 2.1, and that [*] and [*] with respect to Shared Programs will be conducted [*].
Research Commitment. During the Research Term and, if applicable, the Additional Work Period, the parties shall diligently conduct the Collaboration in accordance with the Research Plan, as revised from time to time by the JRC. Without limiting the generality of the foregoing:
(a) Elitra shall devote to the Collaboration an average of [...***...] FTEs during each year of the Research Term, subject to LG Chem's funding obligations under Section 7.1 hereof. To the extent that the Research Plan, as approved by the JRC, requires Elitra to devote additional FTEs to the Collaboration (including FTEs contemplated by Section 3.5(b) but not including any FTEs necessary to perform work during the Additional Work Period contemplated by Section 4.3), LG Chem shall provide funding for such additional FTEs at an initial rate of $[...***...] per year, which amount shall be adjusted on an annual basis by a factor which reflects changes in the Consumer Price Index for San Diego, California as reported as of the date that is thirty (30) days prior to the anniversary of the Effective Date in each applicable year when compared to the comparable statistic for the date that is thirty (30) days prior to the anniversary of the Effective Date in the preceding year.
(b) LG Chem shall devote to any activity for which it is responsible under the Research Plan approximately that number of FTEs as set forth in the Research Plan or such other number of FTEs as is generally accepted practice for similar activities in the pharmaceutical industry, with the expectation that LG Chem shall devote to the Collaboration a maximum of [...***.
Research Commitment